Profile: Caplin Point Laboratories Ltd (CAPL.BO)

CAPL.BO on Bombay Stock Exchange

599.70INR
30 Jan 2015
Change (% chg)

Rs77.60 (+14.86%)
Prev Close
Rs522.10
Open
Rs534.00
Day's High
Rs625.50
Day's Low
Rs486.10
Volume
107,495
Avg. Vol
8,157
52-wk High
Rs625.50
52-wk Low
Rs108.15

Search Stocks
Caplin Point Laboratories Limited operates in the pharmaceuticals formulations segment. The Company’s products include Aceclofenac, serratiopeptidase and paracetamol tablet, Pantoprazole injection 40mg, Tranexamic acid tab BP 500 milligram, Cycloserine tab 250 milligram, Warfarin sodium tab 5 milligram, 2 milligram,1 milligram, GANCICLOVIR SODIUM 500 milligram, OMEPRAZOLE INJECTION, ALUMINIUM HYDROXIDE Tablets, ARCET Syrup, ASPIRINA Tablets, CAPSULIDE Tablets, DICLOPAR Tablets, DIPIRONA Injection, MAYDIC Tablets, and MADAR Tablets. The Company main areas of focus are in the export of generic medicines to regions, such as Latin America, West Africa, South East Asia among others. The Company holds over 1300 product registrations in these markets.

Company Address

Caplin Point Laboratories Ltd

NARBAVI
No. 3, Lakshmanan Street, T. Nag
CHENNAI     600017
P: +9144.28156653
F: +9144.28154952

Company Web Links

Search Stocks